CoreWeave is locking in long-term, high-value contracts with leading AI players. In a significant development, CoreWeave (CRWV) shares rallied 10.9% in the last trading session, closing at $102. This surge follows a robust performance over the past month, with the stock gaining 15.2%.
The recent momentum is largely attributed to CoreWeave’s multi-year deal with Anthropic, aimed at powering the development of Claude AI models. Additionally, the company has expanded its long-term agreement with Meta Platforms, Inc., valued at approximately $21 billion, further solidifying its position in the AI sector.
Despite the positive stock performance, analysts expect CoreWeave to report a quarterly loss of $0.90 per share, reflecting a year-over-year change of -50%. However, revenues are projected to reach $1.96 billion, marking a staggering increase of 99.7% from the previous year.
CoreWeave’s revenue backlog has also reached an impressive $66.8 billion, indicating strong future earnings potential. The company recently secured an $8.5 billion delayed draw term loan facility and issued $1.75 billion in senior notes to bolster its financial standing.
In a recent upgrade, Macquarie raised CoreWeave’s rating from Neutral to Outperform, signaling increased confidence in the company’s growth trajectory. Furthermore, CoreWeave is expected to be among the first to deploy NVIDIA’s advanced Rubin platform in the second half of 2026, which could enhance its operational capabilities.
Currently, CoreWeave carries a Zacks Rank #3 (Hold), reflecting a cautious outlook among analysts. Insider stock sales under pre-arranged 10b5-1 plans are generally considered non-discretionary, adding a layer of complexity to the stock’s performance.
As the market reacts to these developments, observers are keenly watching how CoreWeave will leverage its new contracts and financial resources to navigate potential challenges ahead. Details remain unconfirmed regarding the long-term impacts of these agreements on the company’s overall financial health.
